Loading interface...

Vpl 2.5 mg Injection

Manufactured bySamarth Life Sciences Pvt. Ltd.
ContainsVerapamil
Description
Vpl 2.5 mg Injection is used to treat life-threatening heart rhythm disorders. It belongs to a group of medicines called Group IV antiarrhythmics.

Side effects

Major & minor side effects for Vpl 2.5 mg Injection

  • Dizziness and fainting
  • Shortness of breath
  • Swelling of legs
  • Pale skin
  • Redness of face, neck, arms and chest
  • Increased sweating
  • Headache
  • Pain at the injection site
  • Muscle or joint pain
  • Blurred vision

Uses of Vpl 2.5 mg Injection

What is it prescribed for?

  • Paroxysmal supraventricular tachycardia
  • Atrial flutter and Atrial fibrillation
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed within 1 to 5 minutes after administration.
  • How long do the effects of this medicine last?
    The effect of this medicine lasts for an average duration of 10 to 20 minutes.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendency has been reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to verapamil, other calcium channel blockers, or any other inactive ingredients present along with the formulation.

Cardiogenic shock

This medicine is not recommended for use in patients suffering from a cardiogenic shock due to the increased risk of worsening of the patient’s condition.

Heart block greater than first degree

This medicine is not recommended for use in patients with second or third-degree heart block due to the risk of worsening of the patient's condition.

Sick sinus syndrome

This medicine is not recommended for use in patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Neuromuscular transmission diseases

This medicine is not recommended for use in patients with neuromuscular transmission diseases like myasthenia gravis or advanced Duchenne muscular dystrophy due to the increased risk of worsening of these conditions. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Hypotension

Symptomatic hypotension may occur in patients with volume depletion, aortic stenosis, or patients who are treated with high-dose diuretics. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Itraconazole

Metformin

Simvastatin

Carbamazepine

Disease interactions

Liver Disease

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Kidney Disease

This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Aortic Stenosis

This medicine is not recommended for use in patients suffering from advanced aortic stenosis since it may worsen the patient's condition.

Coronary Artery Disease

This medicine should be used with extreme caution in patients with coronary artery disease due to the increased risk of adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by inhibiting the influx of calcium into the muscles and causes relaxation of the muscles; thereby helps the heart to beat normally.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Group IV antiarrhythmics, Calcium channel blocking agents

Schedule

Schedule H

DailyMed - Verapamil Hydrochloride injection [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 10 June 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d595d9d-af88-474d-b622-d63d786f06a7

Verapamil - DrugBank [Internet]. Drugbank.ca. 2020 [cited 21 May 2020]. Available from:

https://www.drugbank.ca/drugs/DB00661

Securon 2.5 mg/ml IV Intravenous Injection - Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 10 June 2020]. Available from:

https://www.medicines.org.uk/emc/product/979/smpc
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 10 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.